Document Type: Research Articles
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia.
Background: Alcohol consumption has become one of the most common cancer risk factors after smoking.
Nowadays, estimation of the burden of disease attributable to alcohol has become standard in documenting the impact
of health problems, but it has been rarely performed in Indonesia. The aim of this study was to estimate treatment
cost of cancer related to alcohol consumption among the Indonesian population. Methods: This research design was
descriptive with a prevalence-based approach using secondary data. Proportions of cancers were calculated using an
alcohol-attributable fractions (AAF) formula. Treatment costs for eight types of cancer were assessed according to
average treatment cost per patient from the national universal health coverage database for 2016. Result: The top
three AAFs for males were cancers of the pharynx, esophagus and larynx (17.5%, 15.3% and 7.98%, respectively),
while in females they were cancers of the esophagus, pharynx and stomach (2.15%; 1.39%; 0.83%). Among the eight
types of cancer studied, the highest incidence in males was noted for liver cancer (132 cases) while colorectal cancer
was the most common among females (31 cases). Treatment cost for cancers related to alcohol consumption were
highest for colorectak cancer followed by laryngeal and liver cancer (116,083, 98,325 and 93,253 USD, respectively.
Conclusion: The expenditure for treatment of cancers related to alcohol consumption accounts for about 1.71% of
total cancer treatment cost. Since cancers related to alcohol consumption can be considered having an economic
impact in Indonesia, it becomes important for the government to control alcohol consumption so that related healthcare
expenditure can be minimized.